|
Chernakova G.M., Kleshcheva E.A., Hatsukova B.N., Malinnikova E.Yu., Mikhailov M.I.
Chronic hepatitis C and eye diseases: State of the problem
|
№2 / 2017
|
|
Makashova V.V., Kuznetsov S.D., Tutelyan A.V., Shabalina S.V.
Clinical and genetic relationships in patients with chronic hepatitis C
|
№5 / 2016
|
|
Kuznetsova R.S.
The incidence of hepatitis C in the Samara Region
|
№5 / 2016
|
|
Tikhomolova E.G., Osokina A.A., Matveev D.A., Utemova E.D., Kulikova N.V., Fursova E.A., Zhuikova V.I.
The first results of using «3D» interferon-free therapy in real clinical practice in Russia: the experience of the Kirov Region
|
№3 / 2016
|
|
Efremova O.S., Yurin O.G.
Comparative characteristics of major international and national guidelines for the treatment of chronic hepatitis С
|
№3 / 2016
|
|
Shestakova I.V., Popovich L.D., Potapchik E.G., Blokhina N.P.
Possible socioeconomic effect of the introduction of innovative treatment technology for chronic hepatitis C in Russia
|
№2 / 2016
|
|
Tkachenko L.I., Maleev V.V., Tsvetkovskaya T.N.
Role of obesity in the development of metabolic disorders, in the progression of liver fibrosis, and in the outcomes of antiviral therapy in patients with chronic hepatitis C
|
№1 / 2016
|
|
Nikitin I.G., Chulanov V.P., Andreeva K.V., Murashko M.M.
Topical aspects in the organization of medical care for patients with chronic viral hepatitis
|
№1 / 2016
|
|
Nikitin I.G., Popovich L.D., Potapchik E.G.
The economic burden of chronic hepatitis C in Russia
|
№6 / 2015
|
|
Kravchenko A.V., Kanestri V.G., Gankina N.Yu.
Efficacy and safety of antiretroviral therapy regimens containing etravirine for HIV-infected patients
|
№2 / 2015
|
|
Sagalova O.I.
Interferon-free antiviral therapy for chronic hepatitis C
|
№2 / 2015
|
|
Lobzin Yu.V., Kuznetsov N.I., Romanova E.S.
Recombinant Il-1β in the combination therapy of chronic hepatitis C
|
№4 / 2014
|
Русский
